Log in or Sign up for Free to view tailored content for your specialty!
Chronic Kidney Disease News
Empagliflozin lowers kidney disease progression, cardiovascular death in patients with CKD
ORLANDO —Empagliflozin reduced kidney disease progression and cardiovascular death in patients with chronic kidney disease, according to data presented at ASN Kidney Week.
SGLT2 inhibitors may reduce risk, progression of CKD, AKI regardless of diabetes status
ORLANDO — SGLT2 inhibitors reduce the risk and progression of chronic kidney disease and AKI regardless of diabetes status, according to data presented at ASN Kidney Week.
Log in or Sign up for Free to view tailored content for your specialty!
Exclusion of race may lead to classification of living kidney donor as having CKD
ORLANDO —Use of the 2021 Chronic Kidney Disease Epidemiology Collaboration eGFR formula may lead to incorrect classification of Black living kidney donors as having CKD, according to data presented here.
Study shows no detrimental impact of continuing cardiac drugs with advanced CKD
ORLANDO — Patients with chronic kidney disease did not see a change in kidney function when clinicians continued a course of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, according to a study presented here.
Dapagliflozin seen as cost-effective for CKD in the United Kingdom, Germany, Spain
In the United Kingdom, Germany and Spain, dapagliflozin with standard therapy is a cost-effective treatment for chronic kidney disease, according to data published in the Clinical Journal of the American Society of Nephrology.
Clopidogrel plus aspirin lowers risk for second stroke in normal renal function
After a minor stroke or transient ischemic attack, patients with normal vs. impaired renal function treated with ticagrelor plus aspirin had lower risk for stroke at 90 days compared with clopidogrel plus aspirin, researchers reported.
Children with solitary functioning kidney at significant risk for kidney injury
Pediatric patients with a solitary functioning kidney are at a significant risk for developing kidney injury before adulthood, according to data published in Kidney International Reports.
Among patients with non-dialysis CKD, 83% report fatigue
Symptom prevalence ranged among patients with non-dialysis chronic kidney disease, with 24% reporting chest pain and 83% reporting fatigue, according to data published in the Clinical Journal of the American Society of Nephrology.
Finerenone may lower risks for pneumonia, COVID-19 in adults with type 2 diabetes and CKD
Adults with type 2 diabetes and chronic kidney disease using the nonsteroidal mineralocorticoid receptor antagonist finerenone have lower risks for pneumonia and COVID-19, according to findings published in JAMA Network Open.
Patient education increases shared decision-making among older adults with advanced CKD
Among older adults with advanced chronic kidney disease, those who knew the range of kidney treatment options or attended an educational class about their options were more likely to engage in shared decision-making, according to a study.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read